BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1384 related articles for article (PubMed ID: 16297789)

  • 1. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
    Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
    J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.
    Fernández FG; Jaramillo A; Ewald G; Rogers J; Pasque MK; Mohanakumar T; Moazami N
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S255-61. PubMed ID: 15993782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower incidence of bronchiolitis obliterans in pediatric liver-lung transplant recipients with cystic fibrosis.
    Faro A; Shepherd R; Huddleston CB; Lowell J; Gandhi S; Nadler M; Sweet SC
    Transplantation; 2007 Jun; 83(11):1435-9. PubMed ID: 17565316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined organ effect: protection against rejection?
    Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
    Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used.
    De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ
    Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators.
    Ensley RD; Hunt S; Taylor DO; Renlund DG; Menlove RL; Karwande SV; O'Connell JB; Barr ML; Michler RE; Copeland JG
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S142-58. PubMed ID: 1622993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of combined heart and kidney transplantation: a French multicenter study.
    Vermes E; Grimbert P; Sebbag L; Barrou B; Pouteil-Noble C; Pavie A; Obadia JF; Loisance D; Lang P; Kirsch M
    J Heart Lung Transplant; 2009 May; 28(5):440-5. PubMed ID: 19416771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.
    Munster JM; van der Bij W; Breukink MB; van der Steege G; Zuurman MW; Hepkema BG; Verschuuren EA; van Son WJ; Seelen MA
    Transplantation; 2008 Dec; 86(12):1857-63. PubMed ID: 19104434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex mismatch in heart transplantation is associated with increased number of severe rejection episodes and shorter long-term survival.
    Welp H; Spieker T; Erren M; Scheld HH; Baba HA; Stypmann J
    Transplant Proc; 2009; 41(6):2579-84. PubMed ID: 19715978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac operations in solid-organ transplant recipients.
    Mitruka SN; Griffith BP; Kormos RL; Hattler BG; Pigula FA; Shapiro R; Fung JJ; Pham SM
    Ann Thorac Surg; 1997 Nov; 64(5):1270-8. PubMed ID: 9386690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.